12:00 AM
 | 
Aug 03, 2015
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
CompanyBankAnalystCoverageOpinionWk chg7/31 cls
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)JefferiesEun YangUpgradeBuy (from hold)9%$19.13
Yang upgraded, saying the resignation of CEO Marc Beer and COO Craig Fraser could lead to restored investor confidence following disappointing Juxtapid lomitapide sales that led to a significant decline in the...

Read the full 389 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >